B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Navitoclax

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Navitoclax, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

abt
6 shared targets
venetoclax
6 shared targets
apogossypol
4 shared targets
obatoclax
5 shared targets
gossypol
6 shared targets
azd
3 shared targets
tapotoclax
3 shared targets
asterric
2 shared targets
gambogic
4 shared targets
methysergide
2 shared targets
Loading evidence profile...

This evidence profile for Navitoclax is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.